Description
Section I: General Introduction 1. Nanotechnology in the diagnosis of ocular diseases, drug delivery, and therapy: Challenges and opportunities Section II: Perspectives of Nanotechnology in Ocular Drug Delivery 2. An overview of ocular drug delivery systems: conventional and novel drug delivery systems 3. Biopharmaceutical considerations and characterization techniques for the ophthalmic drug delivery therapeutics Section III: Biomedical Applications of Nanocarriers in Ocular Diseases, and toxicity 4. Newer nano-formulated peptides in ocular therapeutics: Issues and approaches 5. An overview of nanocarriers used in corneal diseases 6. Nanomedicine-based Solutions: Nanoemulsions and nanosuspension for ocular diseases 7. Nanotechnology for Surgical Glaucoma treatment 8. Nanotechnology in Glaucoma Conceptual and Clinical Treatment Aspects 9. Polymeric and lipid nanocarriers in glaucoma 10. Lipid-based nanotherapeutic interventions for treatment of ocular diseases: current status and future perspectives 11. Nanotechnology in retinal drug delivery 12. Advances in nanotherapies in the management of microbial keratitis 13. Polymeric Micelles: A Novel Treatment Option for Mycotic Keratitis 14. Use of nanotechnology in dry eye syndrome 15. Advances in nanotechnology-based anti-VEGF agents for the management of ocular angiogenesis. 16. Application of nanotechnology towards reduction of Oxidative stress induced Ocular Diseases 17. Nanotechnology in age-related maculardegeneration (AMD) 18. Nanotechnological strategies for the treatment of diabetic retinopathy: progress and limitations 19. Advanced hydrogel-based platform for ocular drug delivery 20. Nanotoxicity in ocular drug delivery
